Table 2.
Benchmarking of device-associated healthcare-acquired infection rates in our ICU (2008 and current reports) against the reports of International Nosocomial Infection Control Consortium (INICC) in a medical/surgical ICU
DUR/DA-HAI rate | INICCa (2007–2012) | Leblebicioglu et al.b (2003–2012) | Aly et al.c (2004–2005) | This reportd (2018–2019) |
---|---|---|---|---|
CL, DUR/ | 0.54 (0.54–0.54) | 0.65 (0.65–0.65) | 0.88 | 0.80 (0.8–0.84) |
CLABSI rate | 4.9 (4.8–5.1) | 8.5 (8.0–9.1) | 5.5 | 6.70 (4.7–8.8) |
MV, DUR/ | 0.36 (0.36–0.36) | 0.54 (0.54–0.54) | 0.78 | 0.98 (0.97–0.99) |
VAP rate | 16.5 (16.1–16.8) | 22.3 (21.3–23.2) | 9.1 | 2.10 (0.94–3.2) |
UC, DUR/ | 0.62 (0.62–0.62) | 0.88 (0.88–0.88) | 0.95 | 0.73 (0.71–0.76) |
CAUTI rate | 5.3 (5.2–5.8) | 7.9 (7.5–8.4) | 2.3 | 4.30 (2.8–5.7) |